Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity

被引：2
|
作者：
Ceylan, Osman Melih [1 ]
Dikci, Seyhan [1 ]
Genc, Oguzhan [1 ]
Yilmaz, Turgut [1 ]
机构：
[1] Inonu Univ, Dept Ophthalmol, Malatya, Turkey
来源：
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA | 2016年 / 79卷 / 04期
关键词：
D O I：
10.5935/0004-2749.20160080
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：279 / 279
页数：1
相关论文
共 50 条
  • [31] Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
    Xiu-Juan Li
    Xiao-Peng Yang
    Shuang Sun
    Xiao-Bei Lyu
    Heng Jia
    中华医学杂志(英文版), 2016, 129 (23) : 2879 - 2881
  • [32] INTRAVITREAL BEVACIZUMAB AS SUPPLEMENTAL TREATMENT OR MONOTHERAPY FOR SEVERE RETINOPATHY OF PREMATURITY
    Axer-Siegel, Ruth
    Snir, Moshe
    Ron, Yonina
    Friling, Ronit
    Sirota, Lea
    Weinberger, Dov
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (07): : 1239 - 1247
  • [33] Outcomes of intravitreal bevacizumab and laser photocoagulation for treatment of retinopathy of prematurity
    Ahmed, Kamran
    Ali, Anam
    Delwadia, Neil
    Greven, Margaret
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [34] Vitreous Syneresis after Intravitreal Injection of Ranibizumab in Treatment of Retinopathy of Prematurity
    Akkoyun, Imren
    Karadas, Mustafa
    Yilmaz, Gursel
    Tugcu, A. Ulas
    Kayhan, Zeynep
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : E159 - E160
  • [35] Comparison of intravitreal bevacizumab monotherapy and combined laser photocoagulation and intravitreal bevacizumab therapy in the same session in the treatment of aggressive retinopathy of prematurity
    Sabanci, Senol
    Kucuk, Mehmet Fatih
    Suren, Elcin
    Erol, Muhammet Kazim
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [36] Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity
    Cheng, Yong
    Zhu, Xuemei
    Linghu, Dandan
    Liang, Jianhong
    ACTA OPHTHALMOLOGICA, 2020, 98 (08) : E1004 - E1008
  • [37] Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity
    Quiroz-Mercado, Hugo
    Martinez-Castellanos, Maria A.
    Hernandez-Rojas, Myriam L.
    Salazar-Teran, Nelida
    Chan, Robinson Vernon Paul
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (03): : S19 - S25
  • [38] Intravitreal Bevacizumab for Zone II Retinopathy of Prematurity
    Larranaga-Fragoso, Paula
    Peralta, Jesus
    Bravo-Ljubetic, Luciano
    Pastora, Natalia
    Abelairas-Gomez, Jose
    JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2016, 53 (06) : 375 - 382
  • [39] Comparison of intravitreal injection of ranibizumab versus bevacizumab for treatment of type 1 and aggressive retinopathy of prematurity in rural Egypt. A randomized clinical trial
    Tawfik, Ghada Mahmoud
    Shahein, Ezzat A.
    Dabour, Sherif A.
    Hassanein, Dina
    Elshewy, Ahmed Mohamed
    BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
  • [40] Intravitreal ranibizumab injections in patients with retinopathy of prematurity (ROP)
    Maria Zuluaga-Gomez, Liliana
    Montoya-Lopez, Laura
    Hernando Donado-Gomez, Jorge
    IATREIA, 2018, 31 (01) : 34 - 40
12345